Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2014 · limited liability company

$1.3bn reported value +13.5% vs Q1 2025
31positions
74.6%in top 10
4 new 4 added 6 reduced 10 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APOGEE THERAPEUTICS INC COM COM 8,493,321 $368.9m27.64% 27.64% UnchangedShares held: Q3 2024 8.5m, Q4 2024 8.5m, Q1 2025 8.5m, Q2 2025 8.5m
2 OCULAR THERAPEUTIX INC COM OCUL OCUL 12,762,462 $118.4m8.88% 8.88% UnchangedShares held: Q3 2024 12.8m, Q4 2024 12.8m, Q1 2025 12.8m, Q2 2025 12.8m
3 METSERA INC COM COM 3,750,662 $106.7m8.00% 8.00% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.8m, Q2 2025 3.8m
4 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 4,026,331 $80.8m6.05% 6.05% UnchangedShares held: Q3 2024 4.0m, Q4 2024 4.0m, Q1 2025 4.0m, Q2 2025 4.0m
5 KALVISTA PHARMACEUTICALS INC COM KALV KALV 6,728,985 $76.1m5.70% 5.70% AddedShares held: Q3 2024 6.2m, Q4 2024 6.2m, Q1 2025 6.7m, Q2 2025 6.7m +25.0k +25,000 0.4%
6 ORIC PHARMACEUTICALS INC COM ORIC ORIC 6,596,885 $67.0m5.02% 5.02% AddedShares held: Q3 2024 4.4m, Q4 2024 4.4m, Q1 2025 3.2m, Q2 2025 6.6m +3.4m +3,414,358 107.3%
7 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,709 $54.3m4.07% 4.07% UnchangedShares held: Q3 2024 3.9m, Q4 2024 3.9m, Q1 2025 3.9m, Q2 2025 3.9m
8 ORUKA THERAPEUTICS INC COM ORKA ORKA 4,148,428 $46.5m3.48% 3.48% UnchangedShares held: Q3 2024 3.1m, Q4 2024 3.3m, Q1 2025 4.1m, Q2 2025 4.1m
9 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 2,685,448 $40.2m3.01% 3.01% UnchangedShares held: Q3 2024 2.7m, Q4 2024 2.7m, Q1 2025 2.7m, Q2 2025 2.7m
10 PHARVARIS N V COM PHVS PHVS 2,047,620 $36.0m2.70% 2.70% ReducedShares held: Q3 2024 3.4m, Q4 2024 3.2m, Q1 2025 3.1m, Q2 2025 2.0m -1.1m -1,065,100 -34.2%
11 COGENT BIOSCIENCES INC COM COGT COGT 4,755,411 $34.1m2.56% 2.56% ReducedShares held: Q3 2024 5.7m, Q4 2024 5.7m, Q1 2025 5.7m, Q2 2025 4.8m -929.0k -929,000 -16.3%
12 JADE BIOSCIENCES INC COM NEW JBIO JBIO 3,220,364 $32.2m2.41% 2.41% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 3.2m
13 CYTOMX THERAPEUTICS INC COM CTMX CTMX 13,969,882 $31.7m2.38% 2.38% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 14.0m
14 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 639,088 $31.1m2.33% 2.33% ReducedShares held: Q3 2024 0, Q4 2024 765.7k, Q1 2025 1.1m, Q2 2025 639.1k -412.4k -412,430 -39.2%
15 UPSTREAM BIO INC COM UPB UPB 2,295,319 $25.2m1.89% 1.89% UnchangedShares held: Q3 2024 0, Q4 2024 2.3m, Q1 2025 2.3m, Q2 2025 2.3m
16 ERASCA INC COM ERAS ERAS 17,857,083 $22.7m1.70% 1.70% AddedShares held: Q3 2024 16.2m, Q4 2024 16.2m, Q1 2025 16.2m, Q2 2025 17.9m +1.6m +1,640,867 10.1%
17 CRESCENT BIOPHARMA INC. COM CBIO CBIO 1,387,864 $22.4m1.68% 1.68% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.4m
18 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $20.7m1.55% 1.55% UnchangedShares held: Q3 2024 2.2m, Q4 2024 2.2m, Q1 2025 2.2m, Q2 2025 2.2m
19 SAVARA INC COM SVRA SVRA 8,884,263 $20.3m1.52% 1.52% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.3m, Q2 2025 8.9m +5.6m +5,626,624 172.7%
20 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,000,000 $18.6m1.40% 1.40% ReducedShares held: Q3 2024 1.7m, Q4 2024 1.7m, Q1 2025 1.7m, Q2 2025 1.0m -744.4k -744,373 -42.7%
21 ENGENE HOLDINGS INC COM COM 5,046,414 $18.4m1.38% 1.38% UnchangedShares held: Q3 2024 3.6m, Q4 2024 5.0m, Q1 2025 5.0m, Q2 2025 5.0m
22 ASTRIA THERAPEUTICS INC COM CATB CATB 2,457,348 $13.2m0.99% 0.99% UnchangedShares held: Q3 2024 3.5m, Q4 2024 2.5m, Q1 2025 2.5m, Q2 2025 2.5m
23 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,379,965 $10.4m0.78% 0.78% UnchangedShares held: Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 1.4m, Q2 2025 1.4m
24 ABIVAX SA SPONSORED ADS ABVX ABVX 1,345,780 $10.3m0.77% 0.77% UnchangedShares held: Q3 2024 1.3m, Q4 2024 1.3m, Q1 2025 1.3m, Q2 2025 1.3m
25 PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS FRNM FRNM 750,000 $8.0m0.60% 0.60% UnchangedShares held: Q3 2024 750.0k, Q4 2024 750.0k, Q1 2025 750.0k, Q2 2025 750.0k
26 SEPTERNA INC COM SEPN SEPN 540,453 $5.7m0.43% 0.43% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 540.5k
27 SURROZEN INC COM NEW SRZN SRZN 632,931 $5.7m0.42% 0.42% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 632.9k, Q2 2025 632.9k
28 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 4,631,216 $4.9m0.36% 0.36% ReducedShares held: Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 5.0m, Q2 2025 4.6m -391.9k -391,950 -7.8%
29 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 1,609,569 $2.4m0.18% 0.18% UnchangedShares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m
30 CASI PHARMACEUTICALS INC ORD SHS CASIF CASIF 987,259 $1.2m0.09% 0.09% UnchangedShares held: Q3 2024 987.3k, Q4 2024 987.3k, Q1 2025 987.3k, Q2 2025 987.3k
31 TENAX THERAPEUTICS INC COM NEW TENX TENX 98,564 $567.7k0.04% 0.04% ReducedShares held: Q3 2024 208.3k, Q4 2024 208.3k, Q1 2025 208.3k, Q2 2025 98.6k -109.8k -109,769 -52.7%

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
PRAXIS PRECISION MEDICINES I PRAX PRAX 989,985 $37.5m990.0k shares
SOLID BIOSCIENCES INC SLDB SLDB 2,481,400 $9.2m2.5m shares
TREVI THERAPEUTICS INC TRVI TRVI 615,506 $3.9m615.5k shares
APPLIED THERAPEUTICS INC APLT APLT 5,567,709 $2.7m5.6m shares
4D MOLECULAR THERAPEUTICS IN FDMT FDMT 677,600 $2.2m677.6k shares
MERSANA THERAPEUTICS INC 3,574,325 $1.2m3.6m shares
CENTURY THERAPEUTICS INC IPSC IPSC 2,498,069 $1.2m2.5m shares
TENAYA THERAPEUTICS INC TNYA TNYA 1,555,556 $886.8k1.6m shares
GLYCOMIMETICS INC 3,000,000 $630.0k3.0m shares
INSTIL BIO INC TIL TIL 33,177 $576.0k33.2k shares